Delving into the Latest Updates on Bopin (Shanghai) Biomedical Technology Co., Ltd. with Synapse

Overview

Tags

Skin and Musculoskeletal Diseases

Immune System Diseases

Mesenchymal stem cell therapy

Disease domain score

A glimpse into the focused therapeutic areas

Technology Platform

Most used technologies in drug development

Targets

Most frequently developed targets

No Data

Disease Domain	Count

Endocrinology and Metabolic Disease	1

Top 5 Drug Type	Count

Biological products	1
Mesenchymal stem cell therapy	1

Main purpose: Evaluate the clinical safety and tolerability of hADSCs in the treatment of subjects with knee osteoarthritis, and recommend a safe dose range and RP2D for subsequent studies of this product. Secondary purpose: Preliminary evaluation of the effectiveness of hADSCs in the treatment of subjects with knee osteoarthritis, and provide a basis for the design of subsequent clinical trial programs.

Start Date16 Mar 2023

Sponsor / Collaborator

Bopin (Shanghai) Biomedical Technology Co., Ltd.

[+1]

100 Clinical Results associated with Bopin (Shanghai) Biomedical Technology Co., Ltd.

Login to view more data

0 Patents (Medical) associated with Bopin (Shanghai) Biomedical Technology Co., Ltd.

Login to view more data

100 Deals associated with Bopin (Shanghai) Biomedical Technology Co., Ltd.

Login to view more data

100 Translational Medicine associated with Bopin (Shanghai) Biomedical Technology Co., Ltd.

Login to view more data

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 10 Jun 2026

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

IND Approval

1

Phase 1

Login to view more data